Attached files

file filename
EX-31.2 - FORM 10-Q EXHIBIT 31.2 - SECURE POINT TECHNOLOGIES INCcimsc10q_ex31z2.htm
EX-31.1 - FORM 10-Q EXHIBIT 31.1 - SECURE POINT TECHNOLOGIES INCbimsc10q_ex31z1.htm
EX-32.1 - FORM 10-Q EXHIBIT 32.1 - SECURE POINT TECHNOLOGIES INCdimsc10q_ex32z1.htm
10-Q - 120331 IMSC FORM 10-Q - SECURE POINT TECHNOLOGIES INCaimsc120331_10q.htm



Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Implant Sciences Corporation, a Massachusetts corporation (the “Company”) on Form 10-Q for the period ended March 31, 2012, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Roger P. Deschenes, Vice President, Finance and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

/s/ Roger P. Deschenes

 

Roger P. Deschenes

 

Vice President, Finance and Chief Financial Officer

Date: May 15, 2012

 


This certification accompanies each report of the Company on Form 10-Q and Form 10-K pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by we for purposes of §18 of the Securities Exchange Act of 1934, as amended.

A signed original of this written statement required by §906 has been provided to us and will be retained by us and furnished to the Securities and Exchange Commission or our staff upon request.